Gravity Medical Technology

Gravity Medical Technology develops next-generation stroke intervention devices designed to expand global access to mechanical thrombectomy treatment. The company manufactures the Supernova Revascularization Device, a stent-based thrombus retrieval system with patented spiral fusiform cell design and dynamic strut architecture, and the Neutron Reperfusion Catheter, engineered for smooth trackability and fluoroscopic visibility in acute ischemic stroke management. Both products are integrated within the Neutron Stroke Solution portfolio for comprehensive mechanical thrombectomy intervention. The Supernova device received regulatory approval in India (August 2025) and is supported by clinical evidence from the GRASSROOT trial led by AIIMS, with results published in the Journal of Neurointerventional Surgery. Gravity addresses the clinical gap that 97% of the global population lacks access to stroke treatment, focusing on sustainable, reliable deployment of advanced revascularization technology in underserved regions. The company maintains manufacturing and clinical operations across the United States, Thailand, and India, with active case studies and deployments documented in India, Pakistan, and Southeast Asia. Products feature laser-cut, self-expanding stent platforms with retrievable design and kink-resistant catheters optimized for varied healthcare infrastructure settings.